Physician

Kiran Kumar Chintam, MD

According to 2025 Medicare claims, Kiran Chintam, MD (NPI: 1982930285) practices nephrology in the Columbus, IN market, with the plurality of this provider's patient population coming from Bartholomew, IN. This provider's primary affiliated billing organization is COLUMBUS REGIONAL HEALTH PHYSICIANS, LLC (NPI: 1336510098; TIN: 474898741) and primary practice location at 47274-1682. Chintam is affiliated with the Inspire Health Partners, LLC (ACO ID: A3555) and Caravan Health ACO 50 LLC (ACO ID: A5160), participating under the MSSP model.

Chintam's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 502 traditional Medicare patients, billed 1,324 HCPCS/CPT codes, and received $131,037 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 3,348 prescription claims across 535 beneficiaries totaling $340,355 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 71 claims. Open Payments data shows 12 records totaling $176. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $11,909 to $340,355. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $3,712 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	512	1,238	$107,953
2016	601	1,363	$102,260
2017	595	1,413	$98,292
2018	509	1,332	$91,061
2019	273	725	$45,721
2020	N/R	N/R	N/R
2021	188	387	$31,544
2022	435	1,126	$86,532
2023	457	1,218	$100,307
2024	502	1,324	$131,037

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	146	430	$11,909
2016	138	373	$13,420
2017	131	334	$9,604
2018	118	287	$10,366
2019	80	177	$6,339
2020	65	245	$9,341
2021	169	472	$13,835
2022	311	1,435	$79,262
2023	412	2,346	$194,109
2024	535	3,348	$340,355

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	30	$2,839
2016	N/R	70	$2,233
2017	N/R	56	$2,321
2018	N/R	131	$6,930
2019	N/R	77	$2,230
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	44	$714
2024	N/R	71	$1,051

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	60	64	$130
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	63	63	$98
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	140	200	$88
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	291	411	$61
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	74	211	$57

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	145	8,628	$159,594
Jardiance	Empagliflozin	56	3,471	$68,286
Lokelma	Sodium Zirconium Cyclosilicate	49	2,097	$37,504
Kerendia	Finerenone	12	600	$12,988
Veltassa	Patiromer Calcium Sorbitex	13	349	$9,569

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	17	$369
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	23	$287
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	13	$226
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	18	$170

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	12	$176	Otsuka America Pharmaceutical, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kiran Kumar Chintam, MD?

Tedicare shows public-source Medicare data for Kiran Kumar Chintam, MD (NPI 1982930285), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kiran Kumar Chintam, MD have ACO affiliation data?

Kiran Kumar Chintam, MD is shown with ACO affiliation data for Inspire Health Partners, LLC (MSSP, ACO ID A3555) and Caravan Health ACO 50 LLC (MSSP, ACO ID A5160).

What billing organization is linked to Kiran Kumar Chintam, MD?

Kiran Kumar Chintam, MD is linked to COLUMBUS REGIONAL HEALTH PHYSICIANS, LLC (billing NPI 1336510098) in the available physician profile data.

Does Kiran Kumar Chintam, MD have Open Payments data?

Kiran Kumar Chintam, MD has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.